Glenmede Trust’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.48M Buy
53,535
+1,217
+2% +$115K 0.02% 445
2026
Q1
$4.12M Buy
52,318
+3,819
+8% +$307K 0.02% 472
2025
Q4
$3.52M Buy
+48,499
New +$3.44M 0.02% 488
2025
Q1
$1.49M Sell
26,968
-1,296
-5% -$72.7K 0.01% 604
2024
Q4
$1.57M Sell
28,264
-10,569
-27% -$620K 0.01% 600
2024
Q3
$2.37M Buy
38,833
+6,286
+19% +$377K 0.01% 538
2024
Q2
$1.93M Buy
32,547
+3,033
+10% +$175K 0.01% 559
2024
Q1
$1.7M Buy
29,514
+3,732
+14% +$208K 0.01% 605
2023
Q4
$1.43M Buy
25,782
+8,680
+51% +$447K 0.01% 619
2023
Q3
$852K Buy
17,102
+16,436
+2,468% +$853K ﹤0.01% 696
2023
Q2
$32.9K Hold
666
﹤0.01% 1216
2023
Q1
$32.9K Buy
666
+116
+21% +$5.73K ﹤0.01% 1222
2022
Q4
$26.1K Hold
550
﹤0.01% 1225
2022
Q3
$24K Buy
+550
New +$26.8K ﹤0.01% 1212

Other funds holding EMXC

Glenmede Trust's EMXC Position: Q2 2026 in Review

Glenmede Trust increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 2.3% in Q2 2026, buying an estimated $115K and bringing the position to 53,535 shares worth $5.48M. The position accounts for 0.02% of the portfolio, ranked #445.

Glenmede Trust first reported a position in EMXC in Q3 2022 and has held it in 14 quarters since. 1,021 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.

  • Glenmede Trust held 53,535 shares of iShares MSCI Emerging Markets ex China ETF worth $5.48M as of Q2 2026.
  • Glenmede Trust bought 1,217 iShares MSCI Emerging Markets ex China ETF shares in Q2 2026, an estimated $115K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.02% of Glenmede Trust's portfolio in Q2 2026, its #445 holding.
  • Glenmede Trust first reported a position in iShares MSCI Emerging Markets ex China ETF in Q3 2022 and has held it in 14 quarters since.
  • 1,021 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.